BioSpace News Archive

ProMIS Neurosciences Inc. announced that it has entered into a securities purchase agreement with certain new and existing accredited investors to issue and sell an aggregate of approximately $20.4 million of common share units, each consisting of one of the Company’s common shares and one warrant to purchase one Common Share and pre-funded units, each consisting of one pre-funded warrant to purchase one Common Share and one Warrant.

Immune Biosolutions, a Canadian biotech company based in Sherbrooke, reached a new milestone in developing the first inhaled antibody-based treatment against COVID-19.

Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that the United States Food and Drug Administration (FDA) has accepted the filing of Geron’s New Drug Application (NDA) for imetelstat, its first-in-class telomerase inhibitor, for the treatment of transfusion-dependent anemia in patients with lower risk myelodysplastic syndromes (MDS).

Apollon Inc. , a medtech startup based in Seoul, will collaborate with the Laser Biomedical Research Center (LBRC) at the Massachusetts Institute of Technology (MIT) with the aim of developing and conducting clinical trials of non-invasive CGMs using Raman spectroscopy for the next two years.

Inhibikase Therapeutics, Inc. is evaluating new molecules with multiple mechanisms of action for c-Abl inhibition.